How Defensins Target Bacteria, Not You
Alpha-Defensins
Charge-Based Targeting
Defensins are cationic peptides that are electrostatically attracted to negatively charged bacterial membranes but repelled by the neutral outer leaflet of human cells.
Brogden, Nature Reviews Microbiology, 2005
Brogden, Nature Reviews Microbiology, 2005
View as imageYour body produces defensins that kill bacteria, fungi, and enveloped viruses on contact. These same peptides circulate through your bloodstream, line your gut, coat your skin, and fill your airway surface fluid. Yet they leave your own cells intact. This selectivity is not programmed by a lock-and-key receptor system. It emerges from fundamental differences in how bacterial and human cell membranes are built. For broader context on the defensin family, see the pillar article on alpha-defensins.
The selectivity is not absolute. At high concentrations or in certain disease states, defensins can damage host cells. Understanding the mechanisms that normally prevent this damage explains both how the immune system works and why it sometimes fails.
Key Takeaways
- Defensins carry a net positive charge (+3 to +9) that creates electrostatic attraction to the negatively charged phospholipids on bacterial membranes (Brogden, 2005)
- Human cell membranes contain cholesterol (up to 45% of lipid content), which defensins do not efficiently penetrate; bacterial membranes contain zero cholesterol (Hein et al., 2022)
- HBD-3 (human beta-defensin 3) shows lipid-specific membrane activity, selectively disrupting membranes containing bacterial-type phospholipids (Bohling et al., 2006)
- Phospholipid asymmetry keeps negatively charged phosphatidylserine on the inner leaflet of healthy human cells, hidden from defensin contact (Lad et al., 2007)
- Salmonella evolved specific genes to resist antimicrobial peptides, and mutants lacking these genes cannot survive in macrophages or cause disease (Groisman et al., 1992)
- Defensins use multiple killing mechanisms (membrane pores, intracellular targeting), making resistance through single mutations extremely difficult (Brogden, 2005)
The Charge Difference: Why Bacteria Are Attractive Targets
The most fundamental layer of defensin selectivity comes from electrostatics. All human defensins are cationic peptides, carrying a net positive charge between +3 and +9 at physiological pH. This positive charge is not incidental; it is the primary driver of target selection.
Bacterial cell membranes are negatively charged. The outer leaflet of Gram-negative bacteria contains lipopolysaccharide (LPS), which carries multiple negative charges. The inner membrane contains high concentrations of phosphatidylglycerol (PG) and cardiolipin, both negatively charged phospholipids. Gram-positive bacteria have negatively charged teichoic acids embedded in their cell wall and similar anionic phospholipids in their membrane.
Human cell membranes are different. The outer leaflet of healthy mammalian cells is composed primarily of zwitterionic (electrically neutral) phospholipids: phosphatidylcholine (PC) and sphingomyelin. The negatively charged phospholipids (particularly phosphatidylserine, PS) are actively sequestered on the inner leaflet by flippase enzymes.
Brogden's 2005 review established this charge differential as the primary selectivity mechanism for antimicrobial peptides broadly.[1] Cationic defensins are electrostatically attracted to anionic bacterial surfaces and electrostatically neutral toward (or slightly repelled by) the zwitterionic surfaces of healthy host cells. This is not a subtle distinction. The electrostatic attraction drives the initial binding event that brings defensins into contact with the bacterial membrane, without which no killing can occur.
Cholesterol: The Host Cell Shield
Beyond charge, cholesterol provides a second layer of protection for human cells. Mammalian cell membranes contain substantial cholesterol (ranging from 25% to 45% of total membrane lipid), while bacterial membranes contain essentially none.
Hein and colleagues reviewed defensin-lipid interactions in 2022, documenting that cholesterol in the target membrane reduces defensin activity through multiple mechanisms.[2] Cholesterol increases membrane rigidity, making it harder for defensin molecules to insert into the lipid bilayer. Cholesterol also fills spaces between phospholipid acyl chains, reducing the "gaps" that defensins exploit for membrane penetration. The result is that cholesterol-containing membranes are inherently more resistant to defensin-mediated disruption.
This cholesterol effect is significant enough that some researchers consider it the primary reason defensins spare host cells rather than the charge difference alone. In reality, both mechanisms work together: the charge difference reduces initial binding to host membranes, and cholesterol provides a backup barrier even if binding does occur.
Bacteria that lack cholesterol are exposed to the full membrane-disrupting activity of defensins. Some mycoplasmas, which unusually incorporate cholesterol from their host environment into their own membranes, show partial resistance to defensins. This exception actually proves the rule: when bacteria gain cholesterol, they gain protection.
Phospholipid Asymmetry: The Hidden Negative Charges
Healthy human cells do contain negatively charged phospholipids. They just keep them hidden. Phosphatidylserine (PS), a strongly anionic phospholipid, is actively maintained on the inner (cytoplasmic) leaflet of the plasma membrane by ATP-dependent flippase enzymes.
Lad and colleagues investigated antimicrobial peptide-lipid binding selectivity using surface pressure measurements and neutron reflectivity.[3] Their work demonstrated that antimicrobial peptides bind to and permeabilize vesicles composed of anionic phospholipids but not those formed of electrically neutral phospholipids. Since healthy host cells present only neutral lipids on their outer surface, they evade peptide targeting.
This asymmetry breaks down in specific situations. Apoptotic cells (cells undergoing programmed death) expose PS on their outer leaflet as a signal for phagocytic clearance. Cancer cells often have disrupted membrane asymmetry with increased outer-leaflet PS exposure. Both apoptotic and cancerous cells become more susceptible to defensin activity as a result. This explains the growing interest in defensins as potential anticancer agents, as reviewed by Hein et al.[2]
Lipid-Specific Targeting: The HBD-3 Example
Human beta-defensin 3 (HBD-3) provides a particularly clear example of lipid-specific membrane targeting. Bohling and colleagues studied HBD-3's membrane activity using model lipid systems and found it shows strong preference for membranes containing bacterial-type phospholipids over those containing mammalian-type phospholipids.[4]
HBD-3 has the highest positive charge among human beta-defensins (+11 at physiological pH), which contributes to its broad-spectrum antimicrobial activity. But charge alone does not explain its selectivity. The study showed that specific lipid-lipid and lipid-peptide interactions guide HBD-3 to bacterial membranes. The peptide's amphipathic structure (one face hydrophobic, one face cationic) allows it to insert into anionic lipid bilayers in a specific orientation that promotes pore formation.
This lipid-specific activity extends beyond simple binding. Once HBD-3 encounters a bacterial-type membrane, it undergoes conformational changes that are not triggered by mammalian-type membranes. The conformational change leads to oligomerization (multiple defensin molecules assembling together), which creates the pore structures that kill the bacterium. On mammalian membranes, this conformational trigger does not fire, so even defensin molecules that encounter host cells by chance do not assemble into lethal pores.
What Happens When Selectivity Fails
Defensin selectivity is robust but not perfect. Under certain conditions, defensins can damage host tissues.
High local concentrations. When neutrophils degranulate massively at sites of severe infection, alpha-defensin concentrations can exceed levels at which selectivity is maintained. At very high concentrations, even the charge and cholesterol barriers can be overwhelmed, leading to local tissue damage. This is one mechanism of neutrophil-mediated collateral tissue injury during severe infections.
Inflammatory amplification. In chronic inflammatory diseases, persistent defensin exposure can contribute to tissue damage. Aarbiou and colleagues documented the dual role of defensins in inflammatory lung disease: protective at physiological concentrations, potentially harmful during sustained overproduction.[5]
Gut epithelial interface. In the intestine, Paneth cells secrete alpha-defensins (HD-5 and HD-6) directly into the gut lumen to control microbial populations. Wehkamp and colleagues showed that reduced Paneth cell defensin production is associated with ileal Crohn's disease, suggesting that the balance between defensin-mediated microbial control and mucosal tolerance is critical.[6] Nakamura and colleagues further characterized how Paneth cell defensins shape the enteric microbiota in health and disease.[7] The sibling article on defensins and the gut covers this topic in depth.
How Bacteria Fight Back
If bacterial membranes are inherently vulnerable to defensins, why do any bacteria survive? The answer is that successful pathogens have evolved specific resistance mechanisms.
Groisman and colleagues demonstrated in 1992 that Salmonella typhimurium possesses specific genes required for antimicrobial peptide resistance.[8] Mutants lacking these genes were sensitive to both insect and mammalian antimicrobial peptides, could not survive inside macrophages, and lost virulence in mouse infection models. This landmark study established that antimicrobial peptide resistance is not just a survival mechanism but a virulence factor.
Bacterial resistance strategies include: modifying LPS to reduce its negative charge (making the membrane less attractive to cationic defensins); upregulating efflux pumps that expel defensins from the bacterial surface; producing proteases that degrade defensins before they reach the membrane; and altering membrane phospholipid composition to reduce susceptibility.
However, developing full resistance to defensins is far harder than developing resistance to conventional antibiotics. Brogden documented that defensins kill through multiple simultaneous mechanisms, including membrane pore formation, intracellular process disruption, and metabolic inhibition.[1] A bacterium would need to simultaneously defend against all of these mechanisms, a much higher evolutionary bar than mutating a single antibiotic target. For more on this resistance question, see the cross-cluster article on whether bacteria can become resistant to antimicrobial peptides.
Brook and colleagues added another dimension to the defensin story in 2016, showing that alpha-defensins released from dying neutrophils also control inflammation by inhibiting macrophage mRNA translation.[9] This immunomodulatory function uses the same cationic charge that drives antimicrobial selectivity, but applied to a completely different biological process. For cross-cluster context, see how antimicrobial peptides defend your lungs and beta-defensins across epithelial barriers.
The Selectivity System in Summary
The defensin selectivity system works through layered, independent mechanisms that reinforce each other:
Layer 1: Electrostatic targeting. The cationic charge on defensins creates attraction toward anionic bacterial surfaces and neutrality toward zwitterionic host surfaces. This determines where defensins accumulate and where they do not. Even if a defensin molecule encounters a host cell by random diffusion, the absence of electrostatic attraction reduces its dwell time on the surface, lowering the probability of membrane insertion.
Layer 2: Cholesterol exclusion. Even if a defensin contacts a host cell membrane, cholesterol makes insertion mechanically difficult. The rigid, tightly packed cholesterol-phospholipid matrix resists the conformational rearrangements that defensins need to penetrate and form pores. This is a passive, structural defense that does not require active cellular processes.
Layer 3: Phospholipid asymmetry. Even if electrostatic and cholesterol barriers are partially overcome, the absence of anionic phospholipids on the outer leaflet means defensins cannot undergo the lipid-specific conformational changes and oligomerization events that create lethal pore assemblies. Without the right lipid trigger, defensins remain monomeric and non-lethal on host surfaces.
Layer 4: Concentration thresholds. Below certain concentrations, defensins simply do not have enough molecules present at any single point on a membrane to form multi-molecular pore complexes. Physiological concentrations in healthy tissue are calibrated below the threshold for host cell damage but above the threshold for bacterial killing, because bacterial membranes have lower resistance and defensins accumulate there preferentially.
These four layers explain why defensin selectivity is so robust under normal conditions and predict the specific circumstances (very high concentrations, disrupted membrane asymmetry, chronic inflammation) under which it breaks down. The cross-cluster article on defensins as your body's first line of defense provides the broader immune context for this selectivity system.
The Bottom Line
Defensin selectivity for bacteria over host cells depends on three complementary mechanisms: electrostatic attraction to negatively charged bacterial membranes, exclusion by cholesterol in host cell membranes, and phospholipid asymmetry that hides anionic lipids on the inner leaflet of healthy cells. These mechanisms are robust but not absolute, and high defensin concentrations can cause collateral tissue damage. Bacteria have evolved resistance strategies including membrane charge modification and protease production, but the multi-mechanism nature of defensin killing makes full resistance evolutionarily costly.